Market Newsdesk

Initial Biotechnology Portfolio Includes Therapies for Glioblastoma and Late Stage Rabies

Boca Raton, FL, Nov. 23, 2020 (GLOBE NEWSWIRE) — Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), a development-stage biomedical company focusing on novel treatments for rare diseases today announced it is changing its name to Curative Biotechnology, Inc and has applied for the name change and a trading symbol (CURB) with the Financial Industry Regulatory Authority, Inc. (FINRA). The new corporate name better reflects the commitment to finding therapeutics for patients with rare diseases who have unmet medical needs and the expertise in driving the innovations needed to shape the future of rare drug development. The name and symbol changes are expected to take effect in the first quarter of 2021 upon completion of the FINRA process. The Company expects to refer to itself as Curative Bio.

The Company recently secured bridge financing that included management participation. The non-dilutive bridge loan involved warrants at a premium to the market closing price of CTYX stock on November 18^th. These announcements follow the news of the in licensing of Curative Bio’s first two pipeline development assets: a patented novel monoclonal antibody (mAB) drug conjugate platform from the National Cancer Institute at the National Institutes of Health to treat Glioblastoma (brain cancer) and IMT504, a novel, patented immunotherapy, which could become the first drug ever approved to treat late stage rabies.

The Company also announced that it has added Michael K. Fish to their Board of Directors. Mr. Fish received a B.A. in accounting from Florida Atlantic University and is currently licensed as a CPA by the State of Florida. Mr. Fish founded a Certified Public Accounting firm in South Florida and possesses expertise in all areas of accounting, finance, and taxes for business including experience in the medical, wholesale, and professional services sectors. Mr. Fish has agreed to serve as the Chairman of the Audit Committee of the Board.

Paul Michaels, Chairman and President of CTYX said, “We are pleased to announce this key addition to our Board of Directors. who will help guide our transition to a fully reporting company, and the changing of our Company name to reflect our mission. Our bridge financing will allow us to begin the initial steps in the development of our pipeline. All of these are important milestones in the growth of our Company. We expect to be announcing more important changes and additions in the coming weeks to further strengthen our management team and to expand our product portfolio.”

About Connectyx Technologies Holdings Group, Inc.


http://connectyx.com/

Connectyx is a development-stage biomedical company focusing on novel treatments for rare diseases. The Company is focused on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. At Connectyx, we envision a world where all patients have a therapeutic option.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. CTYX is not yet generating revenues. Although forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subjected to known, unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements, including but not limited our ability to generate sufficient market acceptance for our products and services, our ability to generate sufficient operating cash flow, and general economic conditions. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with OTC Markets from time to time which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Contact:
Connectyx Technologies Holdings Group, Inc.
[email protected]
Paul Michaels
561-418-7725

Tampa, FL, Nov. 23, 2020 (GLOBE NEWSWIRE) — In celebration of the upcoming Super Bowl LV, the Business Connect program is hosting a one-of-a-kind restaurant week. From Dec. 4-13, foodies across the Tampa Bay area and beyond are invited to participate in the “Road to Gameday” Restaurant Week event, which will highlight more than 40 diverse-owned restaurants in Hillsborough, Pinellas, and Pasco Counties. A portion of the proceeds will be donated to Feeding Tampa Bay in support of the fight against hunger in our community. The complete list of participating restaurants can be found HERE.

“The Business Connect program is proud to announce the addition of ‘Road to Gameday’ Restaurant Week as a new event for Super Bowl LV,” said B.J. Waymer, NFL Business Connect. “The last seven months have challenged many independent business owners. Restaurant Week creates an opportunity for us to recognize the talents of local, diverse restaurateurs in Tampa and shine a spotlight on them that will direct additional traffic to their businesses.”

Unfortunately, the restaurant industry has been hit hard by the impact of the COVID-19 global pandemic, especially small businesses. Organizers are hopeful this event will help boost the community’s local establishments through this unprecedented time.

“We know local, diverse-owned restaurants have struggled this year, and our team wants to be part of the solution to help get them back on their feet,” said LaKendria Robinson, Director, Tampa Bay Super Bowl LV Business Connect and Community Outreach. “We hope by leveraging our Host Committee brand and the NFL’s Business Connect program, we can increase exposure and drive business to the 40 participating restaurants. We couldn’t be more excited!”

Participating restaurants meet the following criteria: 51% women, minority, veteran, or LGBTQ+ owned and located in the previously listed counties in the Tampa Bay area. Additionally, each one has high public satisfaction ratings on reputable dining review sites. Each participating restaurant will feature a special pre-fixe menu from which patrons can select, in addition to their standard menu.

There are multiple opportunities to speak with event organizers and select restaurants leading up to the event and throughout the week-long festivities.

For questions about the event, please contact Brooke Skelley by phone at 843.455.2917 or by email at [email protected].

Interested media should contact Kendra Cummings by phone at 813.321.3312 or by email at [email protected].

Stay up to date on this event by visiting the 2020 Super Bowl LV Host Committee website at RoadtoGamedayEats.com. Join the conversation on social media at Facebook.com/TampaBayLV, Twitter.com/TampaBayLV and Instagram.com/TampaBayLV.

About Business Connect Program:

Business Connect is the NFL’s special event supplier diversity and inclusion program. In partnership with the Tampa Bay Super Bowl LV Host Committee, the Super Bowl LV Business Connect program will work proactively to create opportunities for experienced, qualified and certified business owners from local, diverse communities to compete for contracting opportunities related to NFL signature events. In addition to contracting opportunities, the Business Connect program offers networking, educational and business development opportunities to encourage greater business success for each participant. The programming includes a Playbook Workshop series to help vendors prepare for participation in the Super Bowl bidding process and a professional development workshop series focused on new business strategies that help businesses to enhance and manage company growth. Networking opportunities bring together Business Connect vendors and procurement executives from leading local corporations.

###

Attachment

• “Road to Gameday” Restaurant Week Highlights More Than 40 Diverse-Owned, Local Eateries Across Tampa Bay Area

Kendra Cummings
Vistra Communications
8133213312
[email protected]

CINCINNATI, Nov. 23, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer pre-recorded a fireside chat on Tuesday, November 17, 2020.

To register for access to the pre-recorded fireside chat, go to the Events & Presentations section of the Company’s Investor Relations website at https://investor.meridianbioscience.com/ and follow the link provided for the event. The recording will be available until February 15, 2021.

About Meridian Bioscience, Inc.

Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com.

Contact:

Charlie Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone: +1 513.271.3700
Email: [email protected]

Findings Are Part of a Case Study Examining the Relationship Between SDoH and Healthcare Utilization in Colorado

MINNEAPOLIS, MN, Nov. 23, 2020 (GLOBE NEWSWIRE) — via NewMediaWire  — A groundbreaking analysis by Carrot Health of claims data compiled by the Colorado Hospital Association (CHA) determined that a high Carrot Social Risk Grouper® (SRG) score correlates strongly with higher rates of emergency department (ED) super-utilization. The analysis, which combined data from CHA’s On Demand Hospital Information Network (ODHIN) with consumer behavior data from the Carrot MarketView® platform, also found that food insecurity and other underlying social factors were driving ED utilization and readmissions.

Using de-identified ODHIN data on 2.5 million adult patients in Colorado and Carrot Health data encompassing nearly 5.2 million of the state’s adult residents, analysts scored patient risk based on Carrot Health’s proprietary Carrot SRG® taxonomy for measuring and monitoring social determinants of health (SDoH). Carrot SRG scores range from 0 (low) to 99 (high) based on behavioral, social, economic and environmental components including 11 social risk categories: loneliness, housing instability, health literacy, food insecurity, financial insecurity, discord at home, unemployed, uninsured, low socioeconomic status, transportation needs, and unacculturated.

The CHA-Carrot Health partnership also enabled CHA to build an interactive dashboard to help member hospitals gain a better understanding of their specific patient population by identifying those who have been readmitted within 30 days and determining which SDoH contributed to their overall risk. By visualizing and highlighting the relationship between readmissions and SDoH, appropriate guidance can be provided to member hospitals seeking improvement in their quality efforts.

“By partnering with Carrot Health, CHA is providing its members with data to support programs that can reduce ED utilization and readmissions, thereby reducing the total cost of care for everyone,” said Tom Rennell, Senior Vice President, Financial Policy, for CHA, which represents more than 100 member hospitals and health systems throughout Colorado. “Further, with the dashboard, we are giving hospitals the capability to identify an area of focus and allocate appropriate resources to address social risk factors within their own communities. By acknowledging that each hospital and community is unique, our members are empowered to create individualized interventions.” 

Among the analysis’ key findings was a correlation between high risk for various SRG components and observed ED super-utilization. For example, individuals in the top decile of risk for food insecurity super-utilized the ED at nearly 2.9 times the rate of the general population. Those at highest risk for housing instability super-utilized nearly 2.8 times as often, while financial insecurity led to a super-utilization rate nearly 2.7 times higher.

Carrot Health, a leading provider of healthcare solutions powered by consumer data, developed the Carrot SRG to help predict the likelihood of an individual having an adverse health outcome due to SDoH. Scores, which are available for every individual in the U.S., are based on consumer data, primary surveys, research, and Carrot Health’s proprietary consumer and health database. Specific SRG inputs include consumer data variables, ICD-10 Z-codes, independent survey results, peer-reviewed studies, healthcare claims, clinical information, and other proprietary data. Survey results are based on representative samples of consumers across age, gender, insurance type, and socioeconomic status to identify perception of SDoH risks.

“SRG scoring allows healthcare organizations to understand the unique fingerprint of risk and potential barriers to appropriate care that prevent people from leading their healthiest lives,” said Kurt Waltenbaugh, CEO of Carrot Health. “When this fingerprint is applied to an individual and a community, it can help identify the highest opportunity for intervention and which efforts will produce the greatest return on investment. Assessing the risk of a community before investing in a one-size-fits-all intervention can help justify the right investment and the potential savings opportunity.”

Download the case study, Mapping the Correlation Between Emergency Department Utilization and SDoH, here.

About Colorado Hospital Association

Colorado Hospital Association (CHA) is the leading voice of Colorado’s hospital and health system community. Representing more than 100 member hospitals and health systems throughout the state, CHA serves as a trusted, credible and reliable resource on health issues, hospital data and trends for its members, media, policymakers and the general public. Through CHA, Colorado’s hospitals and health systems work together in their shared commitment to improve health and health care in Colorado.

About Carrot Health

Carrot Health believes in enabling a future with no barriers to better health, for everyone. We believe that shining the bright light of data onto our disparities will help us, all working together, to improve health. We provide consumer insights for each and every individual person in the United States to engage patients and members, close gaps in care, and optimize performance for healthcare payers and provider systems. The Carrot MarketView® software platform incorporates social, behavioral, environmental, and economic barriers to health data to deliver a 360-degree view of the consumer, providing actionable insights to inform Growth, Health, and Quality.

Contact:
Liz Goar
[email protected]

TORONTO, Nov. 23, 2020 (GLOBE NEWSWIRE) — CMLS Financial, one of Canada’s largest commercial real estate finance companies, is pleased to announce the appointment of Pierre Bergevin as Senior Vice President and Head of National Advisory. Pierre will lead our commercial real estate advisory business across Canada and will be based in our Toronto office. Pierre has more than 30 years of executive and international experience within the commercial real estate industry including most recently in his role as Managing Partner at a global real estate advisory firm.

This appointment will enhance and support CMLS growth in Canada and the company’s continued commitment to, and investment in, the Canadian commercial real estate market.

“CMLS Financial has a 45+ year history of providing commercial lending services to real estate investors throughout Canada,” says Sam Brown, Senior Vice President, at CMLS Financial. “We are excited to welcome Pierre to the team. His extensive leadership experience, deep relationships, community and client-centric approach and demonstrated success in building businesses complement our strong entrepreneurial culture and enhance our coast to coast service capabilities.”

“CMLS is the perfect environment in which to grow a high-performance financial advisory platform,” says Pierre. “I look forward to expanding the business and creating enhanced value for our clients.”

About CMLS Financial


CMLS
Financial
 is one of Canada’s largest independently owned mortgage lenders, with nine offices across the country. Founded in 1974, the company provides a wide range of commercial lending services, residential mortgages, and institutional services. For more information, visit www.cmls.ca

For more information, contact:
Sam Brown
Senior Vice President
604.687.2118
[email protected]

PRINCETON, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a virtual fireside chat at the Piper Sandler 32^nd Annual Healthcare Conference, being held December 1-3, 2020.

The pre-recorded fireside chat is accessible through the Investors section of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations. The recording will be available at 10:00am ET today through Thursday, December 3, 2020.

About Agile Therapeutics, Inc.

Agile Therapeutics is a women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women.  Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.  Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.

Follow Agile on LinkedIn and Twitter: @AgileTher.

Contact:  
Matt Riley
Head of Investor Relations & Corporate Communications
[email protected]

NORTH BETHESDA, Md., Nov. 23, 2020 (GLOBE NEWSWIRE) — CloudBolt Software, the enterprise leader in cloud management and integration solutions, today announced it has been ranked number 199 on Deloitte’s 2020 Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America, now in its 26^th year. CloudBolt grew 612% in the ranking period, which encompasses 2016-2019. This is the second year in a row CloudBolt has placed on this list, ranking 242 in 2019. In addition to this ranking from Deloitte, CloudBolt ranked 780 on the 2020 Inc. 5000.

CloudBolt’s Chief Executive Officer Jeff Kukowski credits strong demand for company’s cloud management and integration solutions, strong customer satisfaction, and expanding partner ecosystem for the company’s 612% revenue growth.

“CloudBolt is honored to once again earn a place on the Deloitte Technology Fast 500 list,” Kukowski said. “As enterprises make hybrid cloud and multi-cloud the centerpiece of their digital transformation journey, they continue to grapple with the significant challenges around shadow IT, lack of visibility, and integration complexity. With our award-winning cloud management platform, and recent acquisitions of SovLabs and Kumolus, CloudBolt offers the most comprehensive set of solutions to help enterprises improve their cloud automation, cost management, security, and governance initiatives. We look forward to working closely with our customers and partners as they continue to advance digital transformation in 2021 and beyond.”

About Deloitte’s 2020 Technology Fast 500™

Now in its 26^th year, Deloitte’s Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2016 to 2019.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $US 50,000, and current-year operating revenues of at least $US 5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.

About CloudBolt Software

CloudBolt Software is the enterprise leader in cloud management and integration solutions. Our products are simple, so you achieve unrivaled time-to-value; our knowledge is deep, so you have a trusted cloud partner for your journey; our teams are obsessed with your success, so you become the enterprise IT hero. Today, CloudBolt’s award-winning cloud management platform and codeless integration solutions are deployed in enterprises worldwide for hybrid cloud. Backed by Insight Partners, CloudBolt Software is an Inc. 5000 and Deloitte Fast 500 company, winner of the 2020 CODiE awards for cloud management, and featured in Gartner’s Magic Quadrant for Cloud Management Platforms. For more information, visit www.cloudbolt.io or follow us on Twitter @CloudBoltSW.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

PR Contact:
Matt McCarthy
Scratch Marketing + Media for CloudBolt Software
857-919-3912
[email protected]

FARMINGDALE, N.Y., Nov. 23, 2020 (GLOBE NEWSWIRE) — Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer will be participating in the Piper Sandler 32^nd Annual Virtual Healthcare Conference on Wednesday, December 2 and Thursday, December 3, 2020. Management will be available to host one-on-one meetings with investors who are registered to attend the conference throughout the day.

For more information about the conferences or to schedule a virtual one-on-one meeting with management, please contact your conference representative. Alternatively, please contact Misonix’s investor relations firm, JCIR, at [email protected].

About Misonix, Inc.

Misonix, Inc. (Nasdaq: MSON) is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company’s wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company’s history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients. Additional information is available on the Company’s web site at www.misonix.com.

Contact:
Joe Dwyer Chief Financial Officer Misonix, Inc. 631-927-9113	Norberto Aja, Jennifer Neuman JCIR 212-835-8500 or [email protected]

LEXINGTON, Mass. and TEL AVIV, Israel, Nov. 23, 2020 (GLOBE NEWSWIRE) — A new survey from ESG, sponsored by Hunters and other technology vendors on the impact of XDR (Extended Detection & Response) in modern SOC, ¹ highlights opportunities to automate and enhance SOC decision making as organizations grapple with inadequate tools and processes to effectively manage threat detection and response.

XDR adoption is moving fast, with 93% of respondents already working on an XDR project or planning an XDR investment in the next 12 months.

Hunters
, an Israeli cybersecurity pioneer in the space of open XDR, will deliver the research findings through an eBook, “The Impact of XDR in the Modern SOC,” available for download at no cost.

The data pinpoints the opportunities that are driving the rapid uptake of XDR technology to enhance enterprise threat detection and response:

• XDR, the new SOC hub. 38% of respondents using or considering XDR expect XDR to provide a centralized hub for security operations
• Modernization of SOC security analytics. 58% of respondents using or considering XDR see enhancing, aggregating and improving security analytics capabilities as an important role of XDR
• Improving data pipeline and analytics. 40% of respondents believe they can be more effective if they can better ingest real-time security data and analyze complex attacks across multiple security controls
• Detecting complex attacks is top priority. 45% of respondents using or considering XDR see advanced threat detection as their highest priority for XDR

Hunters’ open, knowledge-powered XDR solution addresses all of the requirements identified in the survey and many more. It harnesses threat hunting techniques and machine learning to proactively detect and respond to threats across endpoint, cloud, network, identity, and more. Cloud-delivered, Hunters seamlessly ingests petabytes of organizational data and security telemetry into a data lake and searches for alerts and noisy attack signals, and then uses a proprietary knowledge graph technology to automatically analyze, contextualize, and correlate relevant threat leads. Hunters’ XDR provides analysts with bulletproof Attack Stories and decision automation they can rely on, all across the enterprise.

“The results of this survey demonstrate what we’ve been seeing at Hunters all along: security analysts are expecting more out of SOC technology today, and rightfully so,” said Uri May, co-founder and CEO of Hunters. “That the majority of enterprises are planning to invest in XDR in the coming year is especially telling and gratifying as it underscores that Hunters is in a sector poised for rapid growth.”

Click here to receive the eBook, “The Impact of XDR in the Modern SOC,” available for download on December 1st. To learn more about Hunters’ open, knowledge-powered XDR watch a demo to see how Hunters’ XDR delivers high-fidelity Attack Stories.

About Hunters

Hunters’ open XDR
is built to empower SOC teams with an automated decision support system they can rely on, while optimizing use of the existing security stack. Hunters flexibly integrates with your security tools to extract threat signals across endpoints, cloud, email, network and more. By leveraging a proprietary knowledge graph technology, Hunters effectively contextualizes and correlates both high fidelity and low fidelity threat signals into actionable findings. Hunters’ XDR enables analysts to answer the three biggest questions around detection and response – Is this signal malicious? What actually happened here? What did I miss?

Learn more at Hunters.AI.

MEDIA CONTACT:

Deb Montner, Montner Tech PR
(203) 226-9290
[email protected]

¹ Source: ESG eBook, The Impact of XDR in the Modern SOC, November 2020.

TORONTO, Nov. 23, 2020 (GLOBE NEWSWIRE) — The Investment Funds Institute of Canada (IFIC) today filed its submission to the Financial and Consumer Services Commission of New Brunswick (FCNB) on RULE UP-001 Unclaimed Property – General and RULE UP-002 Unclaimed Property Fees.

In its submission, IFIC commended the government of New Brunswick for adopting legislation and rules on unclaimed property, which will help owners and beneficiaries acquire forgotten or otherwise unknown property.

IFIC recommended a harmonized approach with other jurisdictions in Canada to reduce the regulatory burden for financial institutions that operate across multiple jurisdictions. IFIC also recommended clarifying the roles of dealers and fund managers for reporting and delivering unclaimed properties to FCNB.

About IFIC

The Investment Funds Institute of Canada is the voice of Canada’s investment funds industry. IFIC brings together 150 organizations, including fund managers, distributors and industry service organizations, to foster a strong, stable investment sector where investors can realize their financial goals. By connecting Canada’s savers to Canada’s economy, our industry contributes significantly to Canadian economic growth and job creation.

For more information:

Pira Kumarasamy
Senior Manager, Communications and Public Affairs
[email protected]
416-309-2317